Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Edith Weigert"'
Autor:
Kathleen Schüler, Daniel Bethmann, Sandy Kaufhold, Carolin Hartung, Kathrin Stückrath, Tilmann Lantzsch, Christoph Uleer, Volker Hanf, Susanne Peschel, Jutta John, Marleen Pöhler, Jörg Buchmann, Karl-Friedrich Bürrig, Edith Weigert, Christoph Thomssen, Eva Johanna Kantelhardt, Martina Vetter
Publikováno v:
Diagnostics, Vol 12, Iss 10, p 2527 (2022)
Tumour-infiltrating lymphocytes (TILs) are considered to have prognostic and predictive value for patients with early breast cancer. We examined 1166 breast cancer patients from a prospective, multicentre cohort (Prognostic Assessment in Routine Appl
Externí odkaz:
https://doaj.org/article/f02ec85c499845709dc9eb42e11a057f
Autor:
Stephan Bernhardt, Michaela Bayerlová, Martina Vetter, Astrid Wachter, Devina Mitra, Volker Hanf, Tilmann Lantzsch, Christoph Uleer, Susanne Peschel, Jutta John, Jörg Buchmann, Edith Weigert, Karl-Friedrich Bürrig, Christoph Thomssen, Ulrike Korf, Tim Beissbarth, Stefan Wiemann, Eva Johanna Kantelhardt
Publikováno v:
Breast Cancer Research, Vol 19, Iss 1, Pp 1-14 (2017)
Abstract Background Breast cancer tumors are known to be highly heterogeneous and differences in their metabolic phenotypes, especially at protein level, are less well-understood. Profiling of metabolism-related proteins harbors the potential to esta
Externí odkaz:
https://doaj.org/article/c0b3d072a2094cbb8715d885c5891d44
Autor:
Kristin Reinhardt, Kathrin Stückrath, Carolin Hartung, Sandy Kaufhold, Christoph Uleer, Volker Hanf, Tillmann Lantzsch, Susanne Peschel, Jutta John, Marleen Pöhler, Marcus Bauer, Friedrich Karl Bürrig, Edith Weigert, Jörg Buchmann, Eva Johanna Kantelhardt, Christoph Thomssen, Martina Vetter
Publikováno v:
Breast Cancer Research and Treatment. 196:483-493
Purpose Phosphatidylinositide-3-kinase (PI3K) regulates proliferation and apoptosis; somatic PIK3CA-mutations may activate these processes. Aim of this study was to determine the prevalence of PIK3CA-mutations in a cohort of early stage breast cancer
Autor:
Kathleen Schüler, Daniel Bethmann, Tilmann Lantzsch, Christoph Uleer, Volker Hanf, Susanne Peschel, Jutta John, Marleen Pöhler, Joerg Buchmann, Karl-Friedrich Buerrig, Edith Weigert, Eva Johanna Kantelhardt, Christoph Thomssen, Martina Vetter
Publikováno v:
Cancer Research. 82:P4-07
Introduction. Tumor cells are influenced by their microenvironment, including immune infiltration. These tumor infiltrating lymphocytes (TILs) are considered to have prognostic and predictive value for patients with early breast cancer. The aim of th
Autor:
Vetter, Kathleen Schüler, Daniel Bethmann, Sandy Kaufhold, Carolin Hartung, Kathrin Stückrath, Tilmann Lantzsch, Christoph Uleer, Volker Hanf, Susanne Peschel, Jutta John, Marleen Pöhler, Jörg Buchmann, Karl-Friedrich Bürrig, Edith Weigert, Christoph Thomssen, Eva Johanna Kantelhardt, Martina
Publikováno v:
Diagnostics; Volume 12; Issue 10; Pages: 2527
Tumour-infiltrating lymphocytes (TILs) are considered to have prognostic and predictive value for patients with early breast cancer. We examined 1166 breast cancer patients from a prospective, multicentre cohort (Prognostic Assessment in Routine Appl
Autor:
Marleen Pöhler, Daniel Bethmann, Susanne Peschel, Eva Johanna Kantelhardt, Carolin Hartung, T Lantzsch, Kathleen Schüler, Martin Porsch, Jörg Buchmann, Jutta John, Sandy Kaufhold, Martina Vetter, Volker Hanf, K Stückrath, Ivo Große, Christoph Thomssen, Martin S. Staege, Karl-Friedrich Bürrig, Edith Weigert, Christoph Uleer
Publikováno v:
Breast Care (Basel)
Introduction: Triple-negative breast cancer (TNBC) is considered the most aggressive type of breast cancer (BC) with limited options for therapy. TNBC is a heterogeneous disease and tumors have been classified into TNBC subtypes using gene expression
Autor:
Karl-Friedrich Buerrig, Jutta John, Martina Vetter, Christoph Thomssen, Volker Hanf, Carolin Hartung, Edith Weigert, Christoph Uleer, EJ Kantelhardt, Joerg Buchmann, Susanne Peschel, T Lantzsch
Publikováno v:
Cancer Research. 80:P4-06
Introduction: Triple negative breast cancer (TNBC) is, in general, associated with unfavorable prognosis. However, TNBC it is a heterogenous disease. Thus, we analyzed the prognosis (RFI, OS) of TNBC in association to the molecular subtypes (accordin
Autor:
Jutta John, Katharina Politt, Thorsten Stiewe, Edith Weigert, Eva Johanna Kantelhardt, Frank Bartel, T Lantzsch, Christoph Thomssen, Claudia Wickenhauser, Christoph Uleer, Jörg Buchmann, Susanne Peschel, Volker Hanf, Karl-Friedrich Bürrig, Martina Vetter, Marco Mernberger, Andrea Nist, Marcus Bauer
Publikováno v:
Oncotarget
// Marcus Bauer 1 , Eva Johanna Kantelhardt 2, 3 , Thorsten Stiewe 4, 5, 6 , Andrea Nist 4 , Marco Mernberger 4 , Katharina Politt 4 , Volker Hanf 7 , Tilmann Lantzsch 8 , Christoph Uleer 9 , Susanne Peschel 10 , Jutta John 11 , Jorg Buchmann 12 , Ed
Autor:
Jutta John, Edith Weigert, Volker Hanf, C. Thomssen, Christoph Uleer, Carolin Hartung, T Lantzsch, Susanne Peschel, K-F Bürrig, EJ Kantelhardt, Martina Vetter, Joerg Buchmann
Publikováno v:
Cancer Research. 77:P2-05
Introduction The PiA-study (Prognostic assessment in routine Application, NCT 01592825) was designed as a representative cohort of breast cancer patients to estimate the proportions of traditional and modern prognostic factors. The ASCO-recommended b
Autor:
Edith Weigert
Publikováno v:
The Analytic Situation ISBN: 9781315130996
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a73571d6665e0c8aa666e206c6568c6
https://doi.org/10.4324/9781315130996-19
https://doi.org/10.4324/9781315130996-19